14-Jul-2015 - INTEGRA Biosciences AG

INTEGRA announces $10,000 contribution to Boston’s Dana-Farber Cancer Institute

Following the launch of its limited edition PIPETGIRL pink pipette controller in support of breast cancer research earlier this year - INTEGRA announced it has made a $10,000 contribution to the Susan F. Smith Center for Women’s Cancers at Dana-Farber Cancer Institute in Boston, Mass.

Marc Hamel, Director of US Sales at INTEGRA commented. "During our visit to Dana-Farber Cancer Institute, we learned so much about the incredible work being undertaken at this prestigious patient treatment facility specifically in the area of breast cancer. Empowered by the laboratory community’s enthusiastic response to our PIPETGIRL pipette controller I am delighted that we have reached our first milestone - a $10,000 contribution to Dana-Farber.".

“We are honored to partner with INTEGRA and truly grateful for their generous support of Dana-Farber’s Susan F. Smith Center for Women’s Cancers,” said Courtney Hadden, associate director, corporate partnerships, Dana-Farber and the Jimmy Fund. “INTEGRA’s commitment is admirable and critical to furthering the important work in research and care for women’s cancers taking place at the Center.”

At the beginning of 2015 - INTEGRA decided to make PIPETGIRL its symbol of its commitment to support breast cancer research. Indeed, the company committed to donate 10 € / $ 15 for every purchase of PIPETGIRL to research institutes dedicated to finding a cure for breast cancer.

Facts, background information, dossiers
  • Integra
  • Dana-Farber Cancer…
More about Integra Biosciences
More about Dana-Farber Cancer Institute
  • News

    Buttoned Up Biomolecules

    Increasing our understanding of cellular processes requires information about the types of biomolecules involved, their locations, and their interactions. This requires the molecules to be labeled without affecting physiological processes (bioorthogonality). This works when the markers are ... more

    New blood test detects wide range of cancers

    In a study involving thousands of participants, a new blood test detected more than 50 types of cancer as well as their location within the body with a high degree of accuracy, according to an international team of researchers led by Dana-Farber Cancer Institute and the Mayo Clinic. The res ... more

    New cancer immunotherapy approach combines tumor fighting power with fewer side effects

    Basic research into the dual nature of certain immune system cells has set the stage for a new approach to cancer immunotherapy that avoids some of the shortcomings associated with other methods, scientists at Dana-Farber Cancer Institute report in a new study in the Proceedings of the Nati ... more

  • Research Institutes

    Dana-Farber Cancer Institute

    Since its founding in 1947, Dana-Farber has been committed to providing adults and children with cancer with the best treatment available today while developing tomorrow's cures through cutting-edge research. more